Insulin resistance in non diabetic individuals with acute myocardial infarction and its relationship with acute phase reactants

被引:0
作者
Nath, Smita [1 ]
Mohanty, Rina [2 ]
Patnaik, Uttam Kumar [3 ]
机构
[1] NDMC Med Coll & Hindu Rao Hosp, Dept Med, New Delhi 110007, India
[2] SCB Med Coll & Hosp, Dept Med, Cuttack, Odisha, India
[3] SCB Med Coll & Hosp, Dept Cardiol, Cuttack, Odisha, India
关键词
Acute phase reactants; cardiovascular disease; insulin resistance; HOMEOSTASIS MODEL ASSESSMENT; BETA-CELL FUNCTION; CARDIOVASCULAR-DISEASE; INFLAMMATION; GLUCOSE; SENSITIVITY; UPDATE; CARE;
D O I
10.4103/IJAM.IJAM_9_19
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: The current study was undertaken to assess the prevalence of insulin resistance (IR) in nondiabetic individuals with acute myocardial infarction (AMI) and to study the relationship between IR and acute-phase reactants in patients with AMI and to ascertain its prognostic significance. Materials and Methods: One hundred nondiabetic individuals with AMI were part of the study. A detailed physical examination and estimation of fasting blood sugar, 2 hPost prandial blood sugar (PPBS), fasting serum insulin, highly sensitive c-reactive protein (hsCRP), and lipid profile was done at admission and then after 3 months of follow-up. IR was calculated using Homeostatic model assessment IR (HOMA IR) and HOMA B method. HOMA IR value of >2 was considered as IR. Results: In the present study, the prevalence of IR was 63% (males = 63.4% females = 60.8%). hsCRP levels were elevated in 87.4% (hsCRP = 3.187 +/- 1.4109 [mg/l]) of insulin-resistant individuals and 86.5% normal individuals (hsCRP = 3.950 +/- 1.390 [mg/L]). At the end of 3 months, hsCRP levels in the group with IR was 2.346 +/- 0.883 mg/L and in the group with no IR was 1.779 +/- 0.875 mg/L (P = 0.043). The prevalence of metabolic syndrome in the study population was 24%. Mortality rate was higher in patients with IR at 3.2%. Conclusion: The study shows that the prevalence of IR is high, even in nondiabetic patients with coronary artery disease.Level of Hs CRP which is a marker of inflammation was found to be raised in the entire study population irrespective of insulin resistance status. However, in patients with IR, the level of hsCRP remained high even on follow-up study. IR and acute-phase reactants like hsCRP can be used in addition to the traditional risk factors to evaluate the progress and outcome of cardiovascular disease. The following core competencies are addressed in this article: Medical knowledge, Patient care, Practice-based learning and improvement, and Systems-based practice.
引用
收藏
页码:22 / 27
页数:6
相关论文
共 17 条
  • [1] Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
    Bonora, E
    Saggiani, F
    Targher, G
    Zenere, MB
    Alberiche, M
    Monauni, T
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETES CARE, 2000, 23 (01) : 57 - 63
  • [2] Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population - The Bruneck study
    Bonora, Enzo
    Egger, Georg
    Kiechl, Stefan
    Meigs, James B.
    Willeit, Johann
    Bonadonna, Riccardo C.
    Oberhollenzer, Friedrich
    Muggeo, Michele
    [J]. DIABETES CARE, 2007, 30 (02) : 318 - 324
  • [3] Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus
    Choi, KM
    Lee, KW
    Kim, SG
    Kim, NH
    Park, CG
    Seo, HS
    Oh, DJ
    Choi, DS
    Baik, SH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) : 175 - 180
  • [4] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [5] General cardiovascular risk profile for use in primary care - The Framingham Heart Study
    D'Agostino, Ralph B.
    Vasan, Ramachandran S.
    Pencina, Michael J.
    Wolf, Philip A.
    Cobain, Mark
    Massaro, Joseph M.
    Kannel, William B.
    [J]. CIRCULATION, 2008, 117 (06) : 743 - 753
  • [6] Das Sidhartha, 2007, Metabolic Syndrome and Related Disorders, V5, P136, DOI 10.1089/met.2006.0024
  • [7] Goyal A, 2006, INDIAN J MED RES, V124, P235
  • [8] Joshi Shashank R, 2003, J Assoc Physicians India, V51, P445
  • [9] Inflammation in Atherosclerosis
    Libby, Peter
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (09) : 2045 - 2051
  • [10] Inflammation in Atherosclerosis From Pathophysiology to Practice
    Libby, Peter
    Ridker, Paul M.
    Hansson, Goran K.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (23) : 2129 - 2138